Logos Global Management LP Stoke Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,050,000 shares of STOK stock, worth $14.5 Million. This represents 1.33% of its overall portfolio holdings.
Number of Shares
1,050,000
Previous 1,050,000
-0.0%
Holding current value
$14.5 Million
Previous $14.2 Million
-0.0%
% of portfolio
1.33%
Previous 1.33%
Shares
1 transactions
Others Institutions Holding STOK
# of Institutions
124Shares Held
51.9MCall Options Held
14KPut Options Held
8.8K-
Skorpios Trust8.91MShares$123 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$74.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.72MShares$65.2 Million4.16% of portfolio
-
Baker Bros. Advisors LP New York, NY4.37MShares$60.3 Million0.78% of portfolio
-
Rtw Investments, LP New York, NY4.22MShares$58.3 Million0.95% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $544M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...